Literature DB >> 9213168

High incidence of thrombosis in Fabry's disease.

K Utsumi1, N Yamamoto, R Kase, T Takata, T Okumiya, H Saito, T Suzuki, E Uyama, H Sakuraba.   

Abstract

Although a high incidence of thrombotic accidents in Fabry's disease has been postulated, few investigations have been performed. To clarify the incidence of thrombosis in Fabry's disease, we undertook a systematic study on thrombosis in patients with Fabry's disease including hemizygous males and heterozygous females. Sixty patients with Fabry's disease (45 hemizygotes and 15 heterozygotes) from 36 Japanese families were subjected to clinical, biochemical and genetic investigations. We found that seven patients with Fabry's disease (4 hemizygous males and 3 heterozygous females) had experienced thrombotic accidents. Six of these thrombotic patients developed brain infarctions, including one man who had the complication of recurrent thrombophlebitis. The remaining woman showed central retinal artery occlusion and thrombophlebitis. We demonstrated a high incidence of thrombosis in Fabry's disease. Thrombotic accidents occurred not only in hemizygous males but also in heterozygous females. The complication of thrombotic accidents should be taken into account in patients with Fabry's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213168     DOI: 10.2169/internalmedicine.36.327

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Enhanced endothelium-dependent vasodilation in Fabry disease.

Authors:  G Altarescu; D F Moore; R Pursley; U Campia; S Goldstein; M Bryant; J A Panza; R Schiffmann
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

Review 2.  Renal pathological changes in Fabry disease.

Authors:  A Sessa; M Meroni; G Battini; A Maglio; P L Brambilla; M Bertella; M Nebuloni; F Pallotti; F Giordano; B Bertagnolio; A Tosoni
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

3.  α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.

Authors:  Justin J Kang; Nayiri M Kaissarian; Karl C Desch; Robert J Kelly; Liming Shu; Peter F Bodary; James A Shayman
Journal:  Kidney Int       Date:  2018-11-22       Impact factor: 10.612

4.  High incidence of autoantibodies in Fabry disease patients.

Authors:  P Martinez; M Aggio; P Rozenfeld
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

5.  Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis.

Authors:  R C Reisin; P Rozenfeld; P Bonardo
Journal:  Med Hypotheses       Date:  2020-09-17       Impact factor: 1.538

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.